K9 Myocardial Diseases Flashcards
Dilated Cardiomyopathy (DCM)
Common cardiac dz
Large and giant breeds and cocker spaniel
Male, middle aged to older (4-10y)
Possible causes of DCM
Familial or genetic (cytoskeletal proteins)- Boxer, doberman and PWD
Immune-mediated (B-receptor, a, B-MHC, ADP-ATO translocator protein)
Taurine deficiency (cocker, goldens)
Carnitine deficiency (boxers)
Pathophysiology of DCM
Systolic pump failure
MR secondary
Diastolic failure
Arrhythmias
L-CHF and biventricular failure
Gross pathology of DCM
Moderate to marked dilation of 4 chambers (left heart more severely)
Myocardium thin, pale and flabby
Thin papillary muscles
CS associated with DCM (advancing order)
No CS → exercise intolerance, syncope, resp. distress, abdominal distension, WL (cachexia) →
Sudden death (20-30% boxers and dobermans)
Genotypic stage of DCM
Normal heart
No CS
Occult stage of DCM
Abnormal heart and no CS
May last years, sudden death may be first CS
ID of this stage is important
Sinus arrhythmias and sinus with VPC singlet
Overt stage of DCM
Abnormal heart
CS: heart failure and arrhythmias
Sinus tachycardia, a fib and ventricular tachycardia
PE on a pet with DCM
Tachycardia/ tachypnea, pulse deficits and weak femoral pulses
Soft systolic murmur, S3 gallop
Jug venous distension, abdominal distension with fluid, harsh resp sounds and cool extremities
DX DCM
NT-proBNP elevated or normal with occult DCM
unnecessary if murmur present
What else is seen with ECG rhythms (DCM)
LVE and LAE (tall R waves and wide P waves)
Conduction disturbances
Small complexes with pleural effusion
Thoracic radiographs associated with DCM
Generalized cardiomegaly
Pulm. venous congestion, pulm edema and pleural effusion
Chronic oral therapy management of DCM
Diuretics, Ionotropes and ACE-1,
anti- arrhythmia drugs if needed
Stacked drugs: diuretics, vasodilators
Emergent therapy for DCM
Oxygen, IV Lasix, dobutamine, nitroprusside,
Prognosis for DCM
Poor to guarded
Hours to 2 yrs
DCM in Dobermans
2 causative genetic mutations: pyruvate dehydrogenase kinase (DCM1 and DCM2)
Risk highest with both mutations